Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival.

Andronesi, Ovidiu C; Esmaeili, Morteza; Borra, Ronald J H; Emblem, Kyrre; Gerstner, Elizabeth R; Pinho, Marco C; Plotkin, Scott R; Chi, Andrew S; Eichler, April F; Dietrich, Jorg; Ivy, S Percy; Wen, Patrick Y; Duda, Dan G; Jain, Rakesh; Rosen, Bruce R; Sorensen, Gregory A; Batchelor, Tracy T

Andronesi, Ovidiu C; Esmaeili, Morteza; Borra, Ronald J H; Emblem, Kyrre; Gerstner, Elizabeth R; Pinho, Marco C; Plotkin, Scott R; Chi, Andrew S; Eichler, April F; Dietrich, Jorg; Ivy, S Percy; Wen, Patrick Y; Duda, Dan G; Jain, Rakesh; Rosen, Bruce R; Sorensen, Gregory A; Batchelor, Tracy T.

Afiliação

Andronesi OC; Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Esmaeili M; Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Borra RJH; Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Emblem K; Medical Imaging Centre of Southwest Finland, Department of Diagnostic Radiology, Turku University Hospital, Turku, Finland.
Gerstner ER; Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Pinho MC; Stephen E. and Catherine Pappas Center of Neuro-Oncology, Departments of Neurology, Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Plotkin SR; Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Chi AS; Stephen E. and Catherine Pappas Center of Neuro-Oncology, Departments of Neurology, Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Eichler AF; Stephen E. and Catherine Pappas Center of Neuro-Oncology, Departments of Neurology, Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Dietrich J; Stephen E. and Catherine Pappas Center of Neuro-Oncology, Departments of Neurology, Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Ivy SP; Stephen E. and Catherine Pappas Center of Neuro-Oncology, Departments of Neurology, Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Wen PY; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD 20892, USA.
Duda DG; Center for Neuro-Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02114, USA.
Jain R; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Rosen BR; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Sorensen GA; Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Batchelor TT; Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

NPJ Precis Oncol ; 12017.

Article em En | MEDLINE | ID: mdl-29202103

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google